8-K/A

AMENDMENT NO. 3 TO FORM 8-K

Company: Amneal Pharmaceuticals, Inc.
Filed: March 1, 2019
Period of Report: May 7, 2018
Accession Number: 0001193125-19-059421

View Document ↗ View on SEC.gov ↗